Study suggests long COVID is more prevalent than previously thought
OHSU research in nonhuman primates finds long-term effects in both lean and obese animals.
Coronavirus (COVID-19)
More Coronavirus (COVID-19) Stories
- Latest Stories
Students, trainees help make history
January 04, 2021
Learners from across OHSU programs are administering the vaccine.
OHSU COVID-19 vaccine plan for high-risk health care workers
December 15, 2020
Oregon Health & Science University will be among the first “prepositioning” sites in Oregon to receive 975 doses of the Pfizer BioNTEch COVID-19 vaccine Tuesday, Dec. 15.
Actualización Sobre el Ensayo Clínico de OHSU de la Vacuna Contra el COVID-19
December 14, 2020
Individuals who have high risk for infection are being prioritized for enrollment into national study.
OHSU COVID-19 Vaccine Clinical Trial Update
December 14, 2020
Individuals who have high risk for infection are being prioritized for enrollment into national study.
Gov. Kate Brown names OHSU executive as special adviser for COVID-19 vaccination implementation
December 11, 2020
Connie Seeley tapped to help direct Oregon’s distribution strategy.
OHSU adjusts low-barrier test sites for COVID-19
December 07, 2020
First two hours daily will be reserved for priority groups.
Acclaimed OHSU HIV researcher appointed to COVID-19 vaccine review group
December 03, 2020
Gov. Kate Brown has named Louis Picker, M.D., to the Western States’ Scientific Safety Review Workgroup.
New review confirms disproportionate impact of COVID-19 on Black, Hispanic populations
December 03, 2020
Primary factor is heightened risk of exposure, transmission.
El ensayo de la vacuna contra el COVID-19 recluta residentes del área metropolitana de Portland
November 30, 2020
OHSU es el único centro de Oregón para el ensayo clínico en fase 3 elaborado por AstraZeneca, Universidad de Oxford.
COVID-19 vaccine trial recruits Portland metro area residents
November 30, 2020
OHSU is the only Oregon site for Phase 3 clinical trial by AstraZeneca, Oxford University.